Ottoflox (Ofloxacin)

Ofloxacin, the active ingredient in Ottoflox, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ottoflox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ottoflox is a fluoroquinolone antibiotic that targets bacterial DNA replication pathways. It is commonly used for: - Urinary tract infection: helps clear the infection and relieve symptoms. - Respiratory tract infection: aids in the eradication of pathogenic bacteria causing bronchitis and pneumonia. - Skin and soft‑tissue infection: assists in reducing bacterial load and promoting healing.

Adverse reactions to Ofloxacin may vary in frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Abdominal pain

Serious or Rare Side Effects: - Tendon rupture or inflammation - Peripheral neuropathy - Severe skin reactions such as Stevens‑Johnson syndrome - QT interval prolongation - Clostridioides difficile‑associated colitis

When using Ofloxacin, several safety considerations should be observed: - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor liver function tests. - Concomitant use with antacids or supplements containing magnesium or aluminum: may reduce absorption. - History of tendon disorders: avoid prolonged therapy. - Pregnancy and lactation: use only if clearly needed. Store at below 25°C: keep in the original packaging, protect from moisture and light.

Ofloxacin can interact with several other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Warfarin : Increased risk of bleeding due to enhanced anticoagulant effect. - Theophylline : Elevated theophylline levels and risk of toxicity. - Cyclosporine : Higher risk of nephrotoxicity and nephritis ‑ monitor renal function.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium/aluminum : Reduced absorption of Ofloxacin. - Non‑steroidal anti‑inflammatory NSAIDs : Potential for increased CNS side‑effects. - Diabetic medications : Possible alteration of glucose control, requiring monitoring.